PERSPECTA

News from every angle

← Back to headlines

Jasper Therapeutics Beats EPS Estimates in Q1

Jasper Therapeutics reported a GAAP EPS of -$0.04, significantly beating analyst estimates by $0.48, indicating a stronger financial performance than anticipated.

14 May, 20:47 — 14 May, 20:47
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed95d ago

Jasper Therapeutics GAAP EPS of -$0.04 beats by $0.48

Read full article →

Related Stories

This vote to sell family shares has been open since …

25m ago

Paramount Seeks $1.88 Billion Bond in Merger Lawsuit

49m ago

Russian Economist Fired After Comparing Economy to 1917; Nestle Assets Targeted

57m ago

Chelsea Chairman Boehly Considers Selling Stake to Clearlake Capital

57m ago